La chaîne d'options affiche les données clés des options sur actions de Safety Shot à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Safety Shot..

Safety Shot (NASDAQ:SHOT) Stock, Chaîne d'Options

Safety Shot

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Safety Shot Inc

Children's Place (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) reported quarterly losses of $(1.52) per share which missed the analyst consensus estimate of $(0.51) by 198.04 percent. This is a 28.81 percent decrease over losses of $(1.18) per share from the same period last year. The company reported quarterly sales of $242.13 million which missed the analyst consensus estimate of $260.62 million by 7.10 percent. This is a 9.61 percent decrease over sales of $267.88 million the same period last year.

Earnings

Earnings Misses

News

PLCE

Children's Place Q1 Adj. EPS $(1.52) Misses $(0.51) Estimate, Sales $242.13M Miss $260.62M Estimate

Somnigroup International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGI#NYSE">SGI</a>) has outperformed the market over the past 15 years by 2.71% on an annualized basis producing an average annual return of 14.7%. Currently, Somnigroup International has a market capitalization of $13.65 billion. 
Buying $100 In SGI: If an investor had bought $100 of SGI stock 15 years ago, it would be worth $796.47 today based on a price of $65.45 for SGI at the time of writing.
<h3>Somnigroup International's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749241823_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Somnigroup International 15 Years Ago Would Be Worth This Much Today

WIIM

Nuveen Insured California Premium Fund Ii

Northann shares are trading higher amid ongoing volatility. The company announced  that it is not aware of any new material developments or pending announcements concerning its business operations that may be contributing to the recent volatile market activity.

Lazydays Holdings, Inc. (NASDAQCM: GORV) ("Lazydays" or the "Company") announced today that it has closed on the asset sale and real estate sale of its Ft. Pierce, Florida location to General R.V. Center, Inc. ("General RV"). The companies expect to complete the remaining divestiture in Longmont, Colorado in the coming weeks.

Asset Sales

GORV

Lazydays Closes Sale Of Ft. Pierce, FL Assets And Real Estate To General RV, With Longmont, CO Divestiture Expected In Coming Weeks

Offerings

BrightView Holdings Enters Underwriting Agreement For 11.6M Shares Of Common Stock

Broadway Technology Inc ("Gaokai"), a leading manufacturer of high-quality PET (polyethylene terephthalate) cups and lids through its operating subsidiary Zhejiang Gaokai New Materials Co., Ltd., announced the execution of an Agreement and Plan of Merger (the "Merger Agreement") for a business combination with Quartzsea Acquisition Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSEAU#NASDAQ">QSEAU</a>, QSEA, QSEAR))) ("Quartzsea"), a publicly traded special purpose acquisition company.
Upon consummation of the transaction contemplated by the Merger Agreement, (i) Quartzsea will be merged with and into Cuisine Universal Packaging Solution, a Cayman Islands exempted company and wholly owned subsidiary of Quartzsea ("Cuisine Universal") (the "SPAC Merger"), and (ii) concurrently with the SPAC merger, CUPS Sub Limited, a Cayman Islands exempted company and wholly owned subsidiary of Cuisine Universal, will be merged with and into Gaokai, resulting in Gaokai being a wholly owned subsidiary of Cuisine Universal (the "Business Combination" and the transactions in connection with the Business Combination collectively, the "Transaction"). Upon the closing of the Transaction, the combined company Cuisine Universal expects to be Nasdaq-listed under the ticker symbol "CUPS."

QSEA

QSEAU

Broadway Technology (Gaokai) Enters Merger Agreement With Quartzsea Acquisition Corp To Complete SPAC Business Combination; Combined Entity To Trade On Nasdaq As "CUPS" Under Cuisine Universal Structure

Despite fears of a sharp slowdown in the labor market, the official nonfarm payrolls report for May showed stronger-than-expected job growth, underscoring the resilience of the U.S. <a href="https://www.benzinga.com/news/econ-s">economy amid macroeconomic uncertainties.</a>
The economy added 139,000 nonfarm payrolls in May, beating expectations of 130,000 yet cooling <a href="https://www.benzinga.com/markets/economic-data/25/06/45812372/us-labor-markets-defies-tariff-concerns-as-nonfarm-payrolls-wages-top-expectations-in-may" target="_blank" rel="noopener">from the previous 147,000.</a> Wage growth also exceeded expectations, with average hourly earnings rising 0.4% month over month and 3.9% year over year. The unemployment rate remained steady at 4.2%.
President Donald Trump celebrated the strong May jobs report, calling the figures "great numbers," while renewing his public pressure on Fed Chair Jerome Powell, urging him <a href="https://www.benzinga.com/markets/economic-data/25/06/45818251/trump-cheers-strong-jobs-data-renews-attack-on-feds-powell-rates-should-be-much-lower">to lower interest rates.</a>
According to Trump, borrowing costs should be "much lower" as they are costing the U.S. economy "a fortune," suggesting the need to refinance maturing debt.
His remarks came after the Congressional Budget Office released updated estimates for Trump's sweeping tax bill, which is projected to add $2.4 trillion to the federal deficit over the next decade.
<h3 class="wp-block-heading">Political Spat Between Trump And Musk Hits Tesla Stock</h3>
A clash between Elon Musk and Trump <a href="https://www.benzinga.com/news/politics/25/06/45817556/trump-musk-feud-sends-betting-markets-into-overdrive-heres-what-traders-see-next">erupted on Thursday</a> after the tech billionaire publicly slammed the tax bill, claiming it was pushed through Congress too fast and never shared with him during his brief tenure as head of the Department of Government Efficiency.
Musk advocated for a leaner federal budget and accused the legislation of reckless spending.
Trump claimed Musk had gone crazy after losing access to government electric vehicle mandates. The president also floated the idea of scrapping all government contracts with Musk's companies, including SpaceX and Starlink, as a cost-saving measure for the budget.
Tensions reached a boiling point when Musk posted: "Time to drop the really big bomb: Trump is in the Epstein files. That is the real reason they have not been made public," yet offering no evidence to support the claim.
The feud sent shockwaves through markets, triggering Tesla Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) worst trading session of the year. Shares tumbled 14% on Thursday, erasing $152 billion in market value and capping a brutal week of double-digit losses.
On Friday, the S&amp;P 500 – tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) – closed at 6,000 points, gaining 1.5% for the week.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/45820264/top-2-alternatives-to-tesla-after-the-musk-trump-breakup">Top 2 Alternatives To Tesla After The Musk-Trump Breakup </a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Broad U.S. Equity ETFs

Global

Econ #s

ETFs

TSLA

US Labor Market Shows Resilience, Tesla Slumps After Trump-Musk Feud: This Week In Markets

Kohls Says On June 5, Announced Closing Of Our Monroe, Ohio E-Fulfillment Center; Will Recognize Cumulative Pre-Tax Charges Of About $25M-$30M; Expect Charges Related To Monroe EFC Closing To Be Incurred In Q2 & Q3 2025

MTEN

Mingteng International Files For Mixed Shelf Of Up to $100M

East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) has outperformed the market over the past 5 years by 4.13% on an annualized basis producing an average annual return of 17.44%. Currently, East West Bancorp has a market capitalization of $12.99 billion. 
Buying $100 In EWBC: If an investor had bought $100 of EWBC stock 5 years ago, it would be worth $218.85 today based on a price of $94.26 for EWBC at the time of writing.
<h3>East West Bancorp's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749240937_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EWBC

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Hyatt Hotels Corporation ("Hyatt" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>), a leading global hospitalitycompany, announced today that all required regulatory approvals have been obtained for its previously announced cash tender offer to purchase all of the outstanding ordinary shares of Playa Hotels &amp; Resorts N.V. ("Playa") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLYA#NASDAQ">PLYA</a>) for $13.50 per share in cash, less any applicable withholding taxes and without interest. The offer is being made pursuant to the previously announced purchase agreement, dated February 9, 2025 (the "Purchase Agreement"), among Hyatt, HI Holdings Playa B.V. ("Buyer") and Playa.

PLYA

Hyatt Secures All Regulatory Approvals For $13.50 Per Share Cash Tender Offer To Acquire Playa Hotels & Resorts Pursuant To February 2025 Purchase Agreement

Raytech Holding Files For Offering Of Up To 30M Ordinary Shares

Wall Street analysts rerated Broadcom Inc&nbsp;(NASDAQ: AVGO)&nbsp;after it reported second-quarter financial results on Thursday. The company reported <a target="_blank" href="https://www.benzinga.com/markets/earnings/25/06/45803595/broadcom-q2-earnings-revenue-eps-beat-estimates-driven-by-robust-demand-for-ai-networking-company-sees-acceleration-in-ai-revenue-ahead" rel="noreferrer noopener">second-quarter revenue</a> of $15 billion, up 20%, beating&nbsp;analyst estimates of $14.99 billion, driven by continued momentum in AI semiconductor solutions and VMware.
The semiconductor company reported second-quarter adjusted earnings of $1.58 per share, beating analyst estimates of $1.56.
The second-quarter&nbsp;AI revenue grew&nbsp;46%&nbsp;to over&nbsp;$4.4 billion,&nbsp;driven by robust demand for AI networking.
Also read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45751360/broadcoms-flexes-ai-muscle-hyperscalers-buying-in" rel="noreferrer noopener">Broadcom Tomahawk 6 Flexes AI Muscle, Hyperscalers Are Buying In</a>
Broadcom expects third-quarter revenue of approximately $15.8 billion, versus estimates of $15.79 billion.&nbsp;
<h2 class="wp-block-heading">Analyst Ratings</h2>
<ul class="wp-block-list">
<li>JP Morgan analyst Harlan Sur maintained Broadcom with an Overweight and raised the <a href="https://www.benzinga.com/quote/AVGO/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from</a> $250 to $325.</li>
<li>Truist Securities analyst William Stein reiterated Broadcom with a Buy and raised the price target from $267 to $295.</li>
<li>Rosenblatt analyst Kevin Cassidy maintained Broadcom with a Buy and raised the price target from $223 to $340.</li>
<li>Cantor Fitzgerald analyst Matthew Prisco reiterated Broadcom with an Overweight and a $300 price target.</li>
<li>Benchmark analyst Cody Acree maintained Broadcom with a Buy and raised the price target from $255 to $315.</li>
</ul>
<h2 class="wp-block-heading">JP Morgan</h2>
JP Morgan analyst Sur is encouraged by the Broadcom team&#8217;s strong line of sight to fiscal 2026 AI revenue profile driven by strong cloud/hyperscaler capex spending trends with continued focus on AI training combined with accelerating AI inference workloads, continued ramp of Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google&#8217;s next-gen TPU v6/v7 3nm AI accelerator ASICs, ramp up of Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) 3nm, and continued strong adoption of ethernet networking.
The continued substantial AI revenues underscore Broadcom&#8217;s strong design win pipeline and confirm Sur&#8217;s belief that internally developed custom ASIC silicon programs offer opportunities for differentiation, efficiency gains, and improved silicon economics.
The analyst said that the fundamentals of cyclical semiconductor businesses are stabilizing across most areas. He stressed that Broadcom continues successfully converting and upselling to its VCF full-stack solution in the infrastructure software business.
Even during macro volatility, the team drives a solid revenue growth profile. Sur estimated that Free Cash Flow generation will be $26 billion this year, up 34% year over year, implying a substantial dividend raise at the end of this fiscal year. Broadcom remains his top pick in semiconductors.
<h2 class="wp-block-heading">Truist Securities</h2>
Broadcom delivered only a modest upside to calendar first-quarter results and the calendar second-quarter guide. Still, Truist Securities analyst Stein noted investors were expecting a more significant beat, considering results from Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and capex outlooks from hyperscale companies.
Stein stated Broadcom&#8217;s long-term position in AI is stable or potentially improving, with significant customer additions (3 current and 4 potential additions) suggesting meaningful potential upside. He also anticipated long-term upside at VMWare.
Broadcom&#8217;s non-AI semi-sales in the calendar first quarter aligned with Stein&#8217;s estimate. Still, management guided to flat quarter-on-quarter growth, implying $4 billion in the calendar second quarter and a ~5% miss compared to his model (not surprising to him, considering that he noted excess channel inventory).
AI computes (custom accelerators) made up ~60% of total AI sales in the calendar first quarter, implying ~$2.6 billion (14% below his estimate of $3.1 billion).
However, Stein remarked that AI networking delivered $1.8 billion in sales, up 170% Y/Y and 33% above his estimate of $1.3 billion. He said that Broadcom expects to shift back to 70/30 compute/networking going forward, implying a double-digit quarter-over-quarter decline in AI networking revenue and an acceleration in custom silicon.
<h2 class="wp-block-heading">Rosenblatt</h2>
Rosenblatt analyst Cassidy writes in the analyst note that Broadcom reported a mostly inline quarter with AI revenue up 46% Q/Q and guided to 60% Y/Y growth.
The analyst said that based on good visibility from its three XPU customers, management believes this growth rate can continue into 2026.
He was interested in adopting Broadcom&#8217;s Ethernet products to scale up connectivity and scaling out. Scale-up unit volumes are 5x to 10x higher than scale-out, Cassidy said.
The analyst noted that the applications are for both LLM training and inference. He said that with three hyper-scale customers ramping up production, management discussed the other four XPU prospects. Cassidy continued recommending the stock for its strong custom ASIC capabilities.
<h2 class="wp-block-heading">Cantor Fitzgerald</h2>
While the second-quarter results and third-quarter guide may be viewed as only a &#8220;skinny beat,&#8221; underneath the covers was a very bullish outlook from Broadcom management, Cantor analyst Prisco stated. Broadcom remains Prisco&#8217;s top pick.
AI Semi revenues were guided at +16% Q/Q and 60% Y/Y for the third quarter, with management then suggesting improved visibility today that gives them confidence that the AI semiconductor business can grow at this ~60% rate for all of fiscal 2025 and 2026, the analyst said.
He said that AI semiconductor revenues are projected to reach $20 billion+ in fiscal 2025 and $30 billion+ in fiscal 2026, delivering meaningful upside to consensus into calendar 2026.
Prisco remarked that non-AI Semiconductor revenues continue to bounce along the bottom while the cash cow Infrastructure Software grows modestly.
<h2 class="wp-block-heading">Benchmark</h2>
On a relatively modest beat and raise, Broadcom&#8217;s shares are off about 4% after hours as investors grapple with results that were closer to the small upside that pummelled Marvell&#8217;s shares last week versus the stronger outperformance delivered by Nvidia when adjusting for their Chinese exposure, analyst Acree stated.
The analyst writes that he understands investors taking profits, particularly considering the company&#8217;s $120-plus run since its recent early April lows of about $139.
He continues to believe Broadcom represents an attractive opportunity as the number two provider of advanced accelerated compute and networking solutions to the AI industry, with direct leverage to the steadily increasing capex budgets of a growing number of the market&#8217;s largest hyperscale investors.
Price Action: AVGO stock is trading lower by 5.25% to $243.28 at the last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45813754/taiwan-semiconductor-powers-alphawaves-2nm-chip-breakthrough-for-faster-ai-and-hpc-connectivity" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor Powers Alphawave&#8217;s 2nm Chip Breakthrough For Faster AI And HPC Connectivity</a></li>
</ul>
Photo by Ken Wolter via Shutterstock

Price Target

Reiteration

Analyst Ratings

Tech

AAPL

AVGO

GOOGL

NVDA

Broadcom Gets Mixed Reactions As Modest Earnings Beat Sparks Profit-Taking

According to several experts in the sector, Bitcoin ETFs and cryptocurrency-related ETFs have made significant progress since launching in January 2024 <a href="https://www.benzinga.com/etfs/currency-etfs/25/01/42971053/bitcoin-etfs-enter-2025-after-massive-first-year">and setting inflow records</a>.
Here's what three Bitcoin-ETF experts had to say about the sector&#8217;s growth, why people are choosing Bitcoin ETFs, what the U.S. buying Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) could mean for demand and validation, and what comes next for cryptocurrency ETFs.
Beating Expectations: The launch of Bitcoin ETFs has been an &#8220;amazing journey&#8221; that could be &#8220;just beginning,&#8221; WisdomTree Global Head of Research Chris Gannatti said at <a href="https://www.youtube.com/watch?v=g-tme4GtysQ">Benzinga's recent ETF event.</a>
"At WisdomTree, we've been amazed to watch the appetite, the adoption," Gannatti said.
Gannatti said it's clear there was pent-up demand for Bitcoin ETFs and everyone has now seen "incredible growth."
WisdomTree was one of the first companies with a Bitcoin ETF with the WisdomTree Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/BTCW#BATS">BTCW</a>).
Bitwise Asset Management Head of Research Ryan Rasmussen echoed the early success of Bitcoin ETFs with his company behind the Bitwise Bitcoin ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITB#NYSE">BITB</a>) and several other crypto-related ETFs.
"The adoption and performance of Bitcoin ETFs since they launched in the US since last January is just incredible," Rasmussen said.
Rasmussen said Bitcoin ETFs broke the one-year record for inflows and continue to see strong demand.
"We're extremely excited about it. Just getting started."
After the launch of the initial batch of Bitcoin ETFs came other funds like the Innovator Uncapped Bitcoin 20 Floor ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/QBF#BATS">QBF</a>), which offers limited downside for investors.
Innovator Director of Product Strategy Andrew Nelson said the initial growth of Bitcoin ETFs is what spurred the company launching a crypto ETF.
"There's room for everybody," Nelson said.
Nelson said Innovator's fund creates additional investment opportunities for investors and another tool in their tool kit when looking for exposure to Bitcoin.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45018551/senator-on-digital-assets-committee-buys-more-bitcoin-etf-shares-2025-is-the-year-for-digital-assets">Senator On Digital Assets Committee Buys More Bitcoin ETF Shares: &#8216;2025 Is The Year For Digital Assets&#8217;</a>
Why Bitcoin ETFs?: When asked why there's room for Bitcoin ETFs alongside investing directly in Bitcoin, the expert panel didn't flinch.
Nelson said Bitcoin ETFs like the one from Innovator provide "unique exposure" for investors.
Summarizing his company's ETF in three sentences, he said it's, "Bitcoin, 20% max loss, and no cap."
The Innovator fund offers an uncapped upside while providing a 20% max loss each quarter for investors. Nelson said this is not something you can engineer on your own just by holding Bitcoin.
Rasmussen echoed this sentiment saying there are different things ETFs can do like derivatives and options along with getting access to "institutional grade custody" of Bitcoin.
With Bitcoin ETFs, there's less risk for asset managers than worrying about self-custody and other aspects for clients, Rasmussen added.
Countries and Companies Adding Bitcoin: Another key growth topic for Bitcoin and Bitcoin ETFs could be the stockpiling of the leading cryptocurrency by countries and companies.
Gannatti said that some see the degree of success Michael Saylor has had with Strategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) buying Bitcoin and they want to follow it.
"People who have achieved great success get great attention," Gannatti said.
Gannatti also said the US being more crypto-friendly isn't a done deal, but things are changing.
"The current administration is pushing the ball down the field in a positive direction."
Without giving a price prediction, Gannatti said if the only goal is to get the price of Bitcoin to go up fast, the U.S. buying Bitcoin could be the quickest way.
Rasmussen highlighted the sector&#8217;s change. The fact that a person predicting some of the things that happened five years ago would have been laughed at and called crazy, he added.
"I think it's crazy that we're seeing corporations and governments buy Bitcoin, not in a bad way," Rasmussen said.
Rasmussen referenced how GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) recently bought Bitcoin. More companies are saying they're adding the cryptocurrency to hedge against national debt, inflation, and geopolitical concerns.
"I still think we're in the early stages of seeing mass adoption by governments and corporations."
Rasmussen added that, "no government wants to be the last mover when it comes to this."
Pension funds that have yet to invest in Bitcoin say they&#8217;d feel comfortable adding cryptocurrency to their portfolios if the U.S. purchases Bitcoin, the panelist added.
"I think that is one of those monumental moments,&#8221; he added.
More demand from countries and corporations could lead the price of Bitcoin higher, Nelson said.
Nelson said the idea is that high demand drives prices higher in a supply-constrained environment. The U.S. buying Bitcoin could be a positive action for the sector. Yet, Nelson added, it might not be the same initial demand that happened when Bitcoin ETFs launched.
"We think it's a positive for the space."
What's Next: Bitwise predicts Bitcoin will hit $200,000 by the end of 2025 and $1 million by 2029. Rasmussen said these are predictions and not investment advice but show confidence in the long term.
Going forward, the company is also launching more ETFs in the cryptocurrency space. This includes covered call income strategy funds around public crypto-companies like Strategy, MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) and Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>).
"We're spending a lot of time thinking about what products do investors want access to," Rasmussen said. 
Innovator has just one current cryptocurrency ETF — QBF. However, the company is closely monitoring the space and the options market to see where the demand is, Nelson said, adding, "We're looking at Ethereum of course, because of its already approved nature.&#8221;
Innvoator also monitors Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) and XRP CRYPTO:XRP). 
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/02/43599972/new-bitcoin-etf-limits-losses-to-20-offers-risk-controlled-exposure">New Bitcoin ETF Limits Losses To 20%, Offers Risk-Controlled Exposure</a></li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
 <iframe loading="lazy" title="Crypto Panel - Virtual ETF Event" width="500" height="281" src="https://www.youtube.com/embed/ozqSFOpMooE?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Specialty ETFs

Exclusives

Interview

$BTC

$ETH

$SOL

$XRP

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

WisdomTree Bitcoin Fund WisdomTree Bitcoin Fund

BTCW

COIN

MARA

MSTR

Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly

EXCLUSIVE: Bitcoin ETF Experts On Past, Present And Future Of Sector — Why US Buying BTC Could Be 'Monumental Moment'

<a href="https://www.bloomberg.com/news/articles/2025-06-06/tesla-s-leader-of-optimus-humanoid-robot-program-leaves-company">https://www.bloomberg.com/news/articles/2025-06-06/tesla-s-leader-of-optimus-humanoid-robot-program-leaves-company</a>

General

'Tesla's Leader of Optimus Humanoid Robot Program Leaves Company'- Bloomberg

Opendoor Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) (the "Company," "Opendoor," "we," "our" or "us"), a leading e-commerce platform for residential real estate transactions, filed a preliminary proxy statement. The proxy statement was furnished in connection with the solicitation of proxies by Opendoor's Board of Directors (the "Board") for use at the Company's Special Meeting of Stockholders to be held on Monday, July 28, 2025, at 9:30 a.m. Pacific Time.
Our Board has adopted and is recommending that our stockholders approve amendments to our Certificate of Incorporation, to effect a reverse stock split of our common stock ("Common Stock") at a ratio ranging from any whole number between 1‑for‑10 and 1‑for‑50, with the exact ratio within such range to be determined by the Board in its discretion (the "Reverse Stock Split"), subject to the Board's authority to determine when to file the amendment and to abandon the other amendments notwithstanding prior stockholder approval of such amendments.

Stock Split

OPEN

Opendoor Technologies Files Preliminary Proxy For July 28 Special Meeting Seeking Shareholder Approval For Reverse Stock Split At Ratio Between 1-For-10 And 1-For-50

On June 5, 2025, Aytu BioPharma, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Lake Street Capital Markets, LLC, as underwriter (the "Underwriter"), relating to the public offering of 1,366,668&nbsp;shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), at a purchase price per share of Common Stock of $1.50&nbsp;(the "Offering Price"), and 8,233,332&nbsp;prefunded warrants in lieu of Common Stock ("Prefunded Warrants") at a purchase price per Prefunded Warrant of $1.4999, each of which enables the investor to purchase one share of Common Stock at an exercise price of $0.0001. Pursuant to the Underwriting Agreement, the Company granted the Underwriter a 30-day option to purchase up to an additional 1,440,000 shares of Common Stock at the Offering Price, less any underwriting discounts and commissions.
Net proceeds from the offering will be approximately $12.9&nbsp;million (or approximately $14.9&nbsp;million if the Underwriter exercises its option to purchase additional shares of Common Stock in full) after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The Company intends to use the net proceeds of this offering for general corporate purposes, working capital and general and administrative expenses, and to execute on a transaction that will enable the Company to exclusively commercialize EXXUATM (gepirone) extended-release tablets.

AYTU

Aytu BioPharma Prices Public Offering Of 1.37M Shares At $1.50 And 8.23M Prefunded Warrants At $1.4999, Expecting Up To $14.9M In Net Proceeds To Support EXXUA Commercialization And Corporate Operations

A federal crackdown on hemp-derived cannabinoids advanced in Congress this week, triggering alarm across the $28 billion U.S. hemp industry. A House subcommittee approved a spending bill that would redefine hemp in a way that bans most intoxicating cannabinoid products, including THCA flower, delta-8 and even some full-spectrum CBD.
The proposed legislation, backed by Rep. Andy Harris, now moves to the full House Appropriations Committee for markup on June 11. If enacted, it could reshape the cannabis landscape far beyond hemp, affecting retailers, manufacturers and state regulators across the country.
All this sets the stage for next week's <a href="https://www.benzinga.com/cannabis-conference">Benzinga Cannabis Capital Conference</a>, taking place June 8–10 at the Marriott Magnificent Mile in Chicago. With more than 120 speaker, the event will focus on capital raising, M&amp;A, state-level policy and how operators are adapting in the face of intensifying federal scrutiny.
<a class="" href="https://www.benzinga.com/cannabis-conference">Get your tickets here</a>.
From California's record-breaking sales decline to regulatory confusion in Argentina and legalization momentum in Chile and Ukraine, here's everything that moved the global cannabis conversation this week.
<h3 class="wp-block-heading">Congress Advances Hemp THC Ban, Industry Warns Of Collapse</h3>
A GOP-led House subcommittee has advanced a bill that would redefine hemp and effectively ban most intoxicating cannabinoid products, including THCA, delta-8, delta-10 and full-spectrum CBD. The measure, included in the FY2026 Agriculture-FDA appropriations bill, passed in a 9–7 vote and now heads to the full House Appropriations Committee for markup on June 11.
Backed by Rep. Andy Harris (R-MD), the bill proposes narrowing hemp's legal uses to fiber, grain, and industrial applications, with an exemption for FDA-approved drugs like Epidiolex. The U.S. Hemp Roundtable warned that the language could destroy a $28.4 billion market and cost more than 300,000 jobs.
Marijuana Moment first reported the bill's advancement and its potential to shut down the market for unregulated cannabinoids, many of which emerged under the 2018 Farm Bill.
"This would eliminate the vast majority of hemp-derived products sold nationwide," said Jonathan Miller, general counsel for the Roundtable. "It's a farmer-crushing, job-killing ban."
Critics, including the Wine &amp; Spirits Wholesalers of America and the National Cannabis Industry Association, say the language is overly broad and risks fueling the illicit market. Analysts like Todd Harrison noted that banning intoxicating hemp would not kill the crop itself but would benefit state-licensed cannabis programs by curbing unregulated competitors.
<a href="https://www.benzinga.com/cannabis/25/06/45802969/federal-crackdown-on-hemp-derived-thc-cannabinoids-advances-in-congress-industry-warns-of-collapse">Full Benzinga article</a>
<h2 class="wp-block-heading">Business Moves</h2>
<h3 class="wp-block-heading">MediPharm Labs Sells BC Facility, Expands EU Production</h3>
MediPharm Labs Corp. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/LABS#TSX">LABS</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/MEDIF#OTCQB">MEDIF</a>) sold its Hope, British Columbia facility to Rubicon Organics (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/ROMJ#TSXV">ROMJ</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ROMJF#OTCQX">ROMJF</a>) for $4.5 million in cash. CEO David Pidduck said the deal will improve MediPharm's cash position and sharpen its focus on pharmaceutical-grade cannabis, particularly through expanded cultivation at its EU GMP-certified Ontario site.
<h3 class="wp-block-heading">Budr Acquires Three Botanist Dispensaries In Connecticut</h3>
Budr Cannabis, which already operates four locations in Connecticut and one in New York, acquired three Botanist dispensaries from Canopy Growth's U.S. subsidiary. The Botanist will remain active in other states including Massachusetts, New York and New Jersey.
<h3 class="wp-block-heading">Village Farms Completes Fresh Produce Divestiture</h3>
Village Farms International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) finalized its exit from the produce business, closing the privatization of its greenhouse-grown fruits and vegetables division. CEO Michael DeGiglio says the move strengthens Village Farms' focus on international cannabis growth, with 160 acres of greenhouse facilities now allocated primarily to cannabis production.
<h3 class="wp-block-heading">Vangst Acquires Se7en Staffing</h3>
Cannabis hiring platform Vangst announced its third acquisition in a year: Se7en Staffing &amp; Employment Solutions, a Missouri-based firm. No financial terms were disclosed. The move reinforces Vangst's position as a leading cannabis workforce provider.
<h2 class="wp-block-heading">Policy &amp; Regulation</h2>
<h3 class="wp-block-heading">Ohio Doubles Daily Flower Purchase Limit</h3>
Ohio cannabis consumers can now purchase up to 2.5 ounces of flower per day, more than doubling the previous 1-ounce limit. The Ohio Division of Cannabis Control issued updated guidance following strong sales since adult-use launched in August 2024. As of late May, recreational purchases had surpassed $539 million.
<h3 class="wp-block-heading">California's Cannabis Sales Hit Five-Year Low</h3>
California's legal cannabis market posted its biggest quarterly drop in history, with Q1 2025 taxable sales falling 11% year-over-year to $1.088 billion. Experts blame a combination of overregulation, rising taxes, and competition from the illicit market. A scheduled excise tax hike from 15% to 19% on July 1 threatens to worsen the trend—though a new bill to delay the increase passed the Assembly unanimously.
<a class="" href="https://www.sfgate.com/cannabis/article/california-cannabis-sales-data-2025-20359112.php">Full article via SFGATE</a>
<h3 class="wp-block-heading">California Assembly Votes to Delay Tax Hike</h3>
The California Assembly voted 74–0 in favor of delaying the cannabis excise tax increase until 2030–31. Sponsored by Assemblymember Matt Haney, the bill now moves to the Senate. UFCW Local 1167 and other labor groups applauded the vote as a win for licensed operators.
<h2 class="wp-block-heading">Global Developments</h2>
<h3 class="wp-block-heading">Ukraine Approves First Medical Cannabis Import</h3>
Ukraine's State Medical Service issued its first permit to import cannabis-based medicines, expanding a program legalized in 2023 after years of war-related trauma. The approved product is registered in the country and marks a key step in opening Ukraine's market to international supply chains. President Volodymyr Zelensky has consistently backed medical cannabis as a tool for public health and recovery.
<a href="https://www.marijuanamoment.net/ukraine-officials-approve-countrys-first-ever-permit-to-import-medical-marijuana-products/?utm_source=newsletteremail.benzinga.com&amp;utm_medium=newsletter&amp;utm_campaign=musk-s-doge-team-leaves-weed-and-destruction-in-gov-office-ohio-s-cannabis-win-california-s-loss&amp;_bhlid=d8b8aa5ea20cc023dca8b4322de155c2ff1b2782">Read more on Marijuana Moment</a>
<h3 class="wp-block-heading">Chile Reopens Debate on Cannabis Legalization</h3>
Chile's Congress reintroduced a long-stalled bill to legalize adult-use cannabis, including home grow and nonprofit collectives. The proposal, backed by the "Regulación por la Paz" coalition and newly supported by President Gabriel Boric, would authorize up to six plants per person and regulated dispensaries. The government's proposed roadmap mirrors Uruguay's public-health-driven model, with four rollout phases planned through 2027.
Read more on <a class="" href="https://elplanteo.com/chile-proyecto-legalizacion-cannabis/">El Planteo</a>
<h3 class="wp-block-heading">Argentina's Cannabis Regulation Enters Legal Limbo</h3>
In Argentina, government agencies INASE and ARICCAME are locked in a bureaucratic standoff that's jeopardizing the legal cannabis industry. Operators have been blocked from renewing licenses, registering genetics, or accessing critical systems, effectively pushing them into regulatory gray zones. Meanwhile, the Health Ministry is demanding compliance with requirements that can't be met, due to the same administrative freeze.
Continue reading on <a class="" href="https://elplanteo.com/inase-ariccame-resolucion-bloqueo/">El Planteo</a>
<h2 class="wp-block-heading">Culture &amp; Industry</h2>
<h3 class="wp-block-heading">Weedmaps Launches Apparel Collab with Robin Eisenberg</h3>
Weedmaps teamed up with LA-based artist Robin Eisenberg for a limited-edition apparel and accessories collection. Known for her cosmic, body-positive illustrations, Eisenberg brings a vibrant twist to cannabis lifestyle fashion. The line includes denim jackets, cowgirl-themed tees, glow-in-the-dark socks, and home accessories—all centered around empowerment and creativity.
Weedmaps says the capsule reflects the inclusive spirit of cannabis culture and marks its first explicitly female-forward drop.
<h2 class="wp-block-heading">Recommended Reads</h2>
<ul class="wp-block-list">
<li><a class="" href="https://www.benzinga.com/cannabis/25/06/45755890/thc-drinks-arent-the-new-beer-theyre-something-else-says-tilray">THC Drinks Aren&#8217;t The New Beer, They&#8217;re Something Else, Says Tilray</a> Tilray's Sam Garfinkel discusses why hemp-derived beverages play a different role than alcohol.</li>
<li><a class="" href="https://www.benzinga.com/cannabis/25/06/45754417/this-us-cannabis-company-did-what-none-of-its-peers-could-in-q1-grow">This US Cannabis Company Did What None Of Its Peers Could In Q1: Grow</a> A rare quarter of positive growth, analyzed against an industry-wide slump.</li>
<li><a class="" href="https://www.forbes.com/sites/javierhasse/2025/06/02/triploid-cannabis/">‘Mutant Marijuana' Is Changing How Weed Is Grown (But It's Not What You Think)</a> An inside look at triploid cannabis genetics and their potential to reshape cultivation.</li>
</ul>

Cannabis

Politics

MEDIF

ROMJF

TSX:LABS

TSX:ROMJ

TSXV:ROMJ

This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago

<a href="https://register.epo.org/application?number=EP18868355" title="https://register.epo.org/application?number=EP18868355">https://register.epo.org/application?number=EP18868355</a>

Biotech

BDSX

Biodesix Has Been Granted European Patent Number EP3698144 Titled "COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER".

ZCMD

Zhongchao Files For Mixed Shelf Of Up to $300M

Small Cap

Opinion

Press Releases

Beverage Brands Are Moving From Flavor to Function and It's Paying Off for Investors

Functional Beverages Surge as Millennials and Gen Z Rethink What Refreshment Means

From Gut Health to Clarity: Why Functional Beverages Are Becoming an Investment Magnet

The $600B Beverage Shift: Why Function Is Outpacing Flavor

Safe Shot to Capitalize on Yerbae's Strong Retail Presence & Distributor Network Following Acquisition

From Gut Health to Recovery Drinks, This Category Is Just Getting Started

Yerbaé Partners with National Foodservice Provider, Guckenheimer

Yerbaé Joins TikTok Shop to Accelerate Growth and Expand Digital Reach

Safety Shot Reminds Shareholders to Vote Their Proxy at the Upcoming Annual Shareholder Meeting

Safety Shot, Inc. Developing Next-Generation Nootropic and Sleep Solutions by leveraging Core 'Feel Better Fast' Expertise

BRBR

CELH

COCO

FIZZ

HAIN

MNST

NSRGY

OTLY

SHOT

SHOTW

TLRY

TSX:TLRY

TSXV:YERB

YERBF

ZVIA

AXIL Brands

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

PMGC Holdings

Flora Growth

FitLife Brands

Lifevantage

Medifast

Mannatech

Natural Alternatives International, Inc. - Common Stock

Natural Alternatives Intl

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Shineco

The Beauty Health Company - Class A Common Stock

Beauty Health

Synergy CHC

United-Guardian

Waldencast

Selection,Of,Alcoholic,Drinks,On,Rustic,Wood,Background

Emerging Markets

Movers & Shakers

Markets

Wellness And Dietary Supplement Company Safety Shot Reports Bringing World&#39;s First Patented Rapid Blood Alcohol Detox Solution To Market

Comments

Safety Shot

Safety Shot (SHOT) Options

Safety Shot (NASDAQ:SHOT) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL